Edition:
United Kingdom

Yasmeen Abutaleb

Trump seeks to base Medicare drug prices on lower overseas rates

25 Oct 2018

WASHINGTON/NEW YORK U.S. President Donald Trump, taking aim at "global freeloading," said on Thursday his administration would seek to lower prescription drug prices by basing what the government's Medicare program pays for some medications on the lower prices paid in other countries.

Trump enacts anti-opioid abuse package in rare bipartisan step

25 Oct 2018

WASHINGTON Medical treatment will be more widely available to opioid abusers while mailing illicit drugs will be more difficult under a measure to fight drug addiction that was signed into law on Wednesday by U.S. President Donald Trump. | Video

Trump to sign anti-opioid abuse package in rare bipartisan step

24 Oct 2018

WASHINGTON, Oct 24 Medical treatment would be more widely available to opioid abusers, while mailing illicit drugs would become more difficult under a rare bipartisan measure aimed at tackling the nation's addiction crisis expected to be signed into law on Wednesday by U.S. President Donald Trump.

FDA proposed crackdown on flavored e-cigs puts Juul on notice

13 Sep 2018

WASHINGTON/LOS ANGELES The U.S. Food and Drug Administration is considering a ban on flavored e-cigarettes from Juul Labs and other companies as it grapples with an "epidemic" of youth e-cigarette use that threatens to create a new generation of nicotine addicts, the agency's head said on Wednesday. | Video

U.S. health secretary says agency can eliminate drug rebates

20 Aug 2018

WASHINGTON U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug purchases, a key element of the Trump administration's plan to lower prescription medicine costs. | Video

U.S. health secretary says agency has power to eliminate drug rebates

20 Aug 2018

WASHINGTON, Aug 20 U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug purchases, a key element of the Trump administration's plan to lower prescription medicine costs.

Merck lowers prices of some drugs after Trump calls out industry

19 Jul 2018

Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for consumers.

Merck lowers prices of some drugs after Trump calls out industry

19 Jul 2018

July 19 Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a little-used hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for consumers.

Trump told Pfizer CEO price hikes hurt his drug plan - source

11 Jul 2018

NEW YORK/WASHINGTON U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

Pfizer delays drug price hikes after talking with Trump

11 Jul 2018

WASHINGTON/NEW YORK Pfizer Inc said on Tuesday it was deferring drug price increases for no more than six months after the company's chief executive officer had an extensive conversation with U.S. President Donald Trump.

World News